IL17A and multiple sclerosis: All RORγt+ subsets express IL-17, which have been implicated in multiple human chronic inflammatories and autoimmune diseases, including inflammatory bowel disease (IBD) [36], multiple sclerosis [37], rheumatoid arthritis [38], and psoriasis [39].